Whole shaken cultures of 20 random, unidentified actinomycetes were extracted with n-butanol at pH 4.5, 7.0, and 8.5, respectively. Residues of butanol-extractable materials (BXM) were reconstituted (100x) in buffers and freeze-dried. BXM were surprisingly well tolerated in animals and were screened against influenza A viral pneumonia in mice. One culture yielded BXM-80 which suppressed both chemical (LPS) and viral (NDV) pneumonia in mice as well as inhibited rat foot pad edema induced by carrageenin. Aspirin, Butazolidin, hydrocortisone, indomethacin, and prednisolone, which are known to inhibit carrageenin-induced rat foot pad edema were tested against chemical (LPS) and viral (NDV) pneumonia in mice. Only hydrocortisone and prednisolone suppressed LPS pneumonia. All of these 5 compounds failed to inhibit NDV pneumonia. Microbial products are suggested as a source for new and unique anti-inflammatory agents.
pneumonia. All of these 5 compounds failed to inhibit NDV pneumonia. Microbial products are suggested as a source for new and unique anti-inflammatory agents. Actinomycetes. Fermentation and Extraction. During an automobile trip from Florida to Alaska, 94 samples were collected from a wide variety of soils. Samples were taken at least 200 miles apart, placed in sterile 5-ml screw cap vials and stored at -10°C in the laboratory. From these samples, 20 apparently different actinomycetes were isolated using chitin agar medium and were maintained on EMERSON agar slants. Pre-inoculum shaken cultures [50 ml/250 ml (Erlenmeyer flask)] were seeded with suspended growth from an agar slant into M-5 medium (5 g dextrose, 5 g peptone, 5 g yeast extract, and 5 g beef extract in 1 liter of tap water) and Aspirin, Butazolidin, hydrocortisone, indomethacin, prednisolone and xerosin1) were appropriately diluted in 0.5% carboxymethyl-cellulose. Preliminary toxicity tests were done by injecting 0.2-m1 amounts of 2-fold serial dilutions of candidate preparations twice daily I.P. for 3 days into groups of 10 mice each. The mice were observed for 7 days and symptoms and mortality and necropsy findings were recorded. The LD0 was used as the highest dosage to be used in further tests. All experiments were terminated 3 days after instillation of LPS, NDV, and IAV when inflammation, manifested as pneumonia, was maximal. The lungs of each mouse were weighed individually and scored as previously described4). The mean lung weights, standard derivations, and standard errors of the various groups were calculated. The statistical significance of the differences between control and treated groups was determined, using the STUDENT T test.
Results Table I summarizes pertinent data on butanol-extractable materials (BXM) obtained from each of 20 unidentified actinomycete cultures. These preparations represented a 100 x concentration of BXM from whole shaken cultures harvested at maximal growth. Pooled, whole shaken cultures (7.5 liters) to 828 mg/liter averaging 293 mg/liter. These preparations were surprisingly well tolerated in mice receiving a single I.P. injection. Of the 60 preparations tested, 50 were well tolerated (LD0) at > 200 mg/kg and only 2 were lethal at < 50 mg/kg. It will be seen that of 20 actinomycete cultures, BXM-33 Average lung weight reduced by >75 mg . Table 2 . Suppression of influenza A virus (IAV) pneumonia in mice by butanol-extractable materials (BXM) of actinomycete culture 80 (See Table 1 and BXM-80 contained biologically active materials. Details of the data on BXM-80 are shown in Table 2 for illustrative purposes.
BXM-33 and BXM-80 failed to inhibit Candida albicans, Succharomyces cerevisiae, Escherichia coli, Pseudomonas aeruginosa, Salmonella schottmuelleri, or Streptococcus pyogenes in vitro. Each preparation was tested at levels of 1, 0.1 and 0.01 mg/ml. Whatman filter paper (no. 4) strips were immersed in test solutions, carefully drained and placed on nutrient agar plates. One hour later, perpendicular to the filter strip, 24-hour broth cultures were surface-streaked on the agar. Bacterialinoculated plates were incubated at 37°C and those with yeasts at room temperature. The inoculated plates were examined at 20 hours to determine inhibitory effect. Table 3 summarizes data from typical experiments, showing the effects of selected anti-inflammatory agents on LPS and NDV pneumonia in mice. It will be seen that hydrocortisone, prednisolone, xerosin and BXM-80 suppressed LPS pneumonia in mice, whereas aspirin, Butazolidin and indomethacin failed to do so. It will also be seen that xerosin and BXM-80 suppressed NDV pneumonia.
Arrangements were made with Dr. SOLOMON MARGOLIN (A.M.R. Inc., Princeton, N. J.) for standard pharmacological tests. BXM-80 was tested in rats and dosage levels of 200, 100, and 50 Ing/ kg against the foot pad edema produced by carrageenin11) and compared with indomethacin at 3 mg/kg. Both BXM-80, at all 3 dosages, and indomethacin significantly (P<0.01) inhibited rat foot pad edema produced by carrageenin. Further, BXM-80 was found active (< 50 mg/kg) in similar tests using adrenalectomized rats and to exhibit considerable analgesic activity at doses of 25, 50, and 100 mg/kg in edema induced in rats by silver nitrate although little anti-inflammatory effects were observed at these levels.
Cultures 33, 64 and 80 that yielded active preparations (Table 1) were found to do so reproducibly when fermentations and extractions were repeated. All of 36 consecutive replicate fermentations and extractions yielded preparations of BXM-80 of comparable potency (Table 3) . Similarly, all of 7 and 5 consecutive preparations of BXM-33 and BXM-64, respectively, were found to reduce the average lung weights by > 100 mg in mice instilled with LPS at dosage levels 50 mg/kg or less.
Preliminary developmental studies were done on BXM-80 using mean lung weight reduction of > 100 mg (LWR) of LPS pneumonia as the bioassay. Whole culture, beer, and mycelium were each extracted with butanol in the usual manner (see Materials and Methods) and the results were as follows: Whole culture: yield=433 mg/liter; LWR=50 mg/kg. Beer: yield 111 mg/liter; LWR= 50 mg/kg; Mycelium: yield= 863 mg/liter; LWR= <50 mg/kg; indicating that mycelium was the best source of BXM-80. Filtration of aqueous solutions of BXM-80 through Whatman #4 paper and Nalgene 0.45 1a pads did not reduce its potency (LWR= 50 mg/kg) but removed more than 75 % of the total solids. Further developmental studies are in progress and the results will be published elsewhere.
Discussion
The data presented here support the concept that microorganisms can provide unexpectedly rich sources of unique pharmacodynamic substances. Simple solvent extraction of 20 randomly isolated actinomycete cultures yielded preparations that were generally well tolerated in animals, at least one of which was pharmacologically active. BXM-80 shares many anti-inflammatory activities with the bacterial product, xerosin1), but differs in its solubility in butanol, a property that should facilitate chemical purification. The potential utility of anti-inflammatory agents that also suppress viral pneumonia is obvious.
The applicability of viral (NDV) and chemical (LPS) pneumonia in mice as bioassays in evaluating anti-inflammatory agents has been described. Both IAV and NDV produce a typical interstitial viral pneumonia',').
IAV pneumonia was selected for the primary screen because it represents a typical rapidly fatal viral infection in which the viral titer is maximal 18 hours after infection and declines during the development of pulmonary lesions"). On the other hand, NDV does not replicate in mouse lungs but produces pneumonia by the toxic effects of large numbers of NDV virions thus paralleling THE JOURNAL OF ANTIBIOTICS DEC. 1977 many features of the natural disease in which viral titers are minimal or declining during active disease8 '9) . In contrast, chemical pneumonia produced in mice by instillation of endotoxin (LPS) was characterized by desquamation, atelectasis, lymphocytic infiltration and edema4). Hydrocortisone has been shown to suppress LPS pneumonia but not NDV pneumonia. Previous studies have shown that daily injections of hydrocortisone12) and xerosin7,13) inhibited virus-induced Rous sarcoma in chicks14) resulting in small, hard, circumscribed tumors. Such tumors were obtained with hydrocortisone only when injections were begun before infection, whereas treatment with xerosin could be delayed until the day the tumors first appeared in the wing web. It will be recalled that when mycelial extracts of 55 random, unidentified actinomycete cultures were screened directly against virus induced Rous sarcoma in chicks, 2 significantly and consistently delayed the latent period for tumor production15).
